Caribou Biosciences, Inc.
$CRBU
Public valuation for Caribou Biosciences, Inc. (CRBU). Fair value, signal, and key metrics — no sign-in required.
Current Price
$1.46
16% Overvalued
Fair Value Estimate
$1
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $12.00
722% higher than current
Key Metrics
Market Cap
$144.8M
Operating Margin
-1096.4%
Revenue Growth
32.3%
Get free watchlist alerts
Join the waitlist for valuation updates on $CRBU and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.